The Zanubrutinib Market represents the global industry surrounding the development, distribution, and clinical application of zanubrutinib-based therapies for treating B-cell malignancies and other hematologic cancers. According to Growth Market Reports, the market is experiencing robust growth as precision medicine, targeted oncology, and innovative hematology treatments continue transforming cancer care.

growthmarketreports.com

Zanubrutinib Market Size to Hit USD 11.79 Billion by 2034 | CAGR 17.8%

The global zanubrutinib market reached USD 2.7 billion in 2025, driven by rising B-cell malignancy prevalence and expanding regulatory approvals worldwide.